Enhancing generalizability and efficiency in clinical trials through dynamic information borrowing for both experimental and control arms: A simulation study

Author:

Yang Jiaying1ORCID,Li Guochun1

Affiliation:

1. Department of Public Health School of Medicine & Holistic Integrative Medicine Nanjing University of Chinese Medicine Nanjing China

Abstract

AbstractAimUtilizing external information in clinical trials enhances validity by including a wider population and expedites the implementation of adaptive designs, ultimately improving research efficiency. However, current research focused on scenarios in which only the control group benefited from the utilization of external information, while trials involving external information in both experimental and control arms were more complex and might pose challenges when applied in real‐world settings.MethodsTo address these concerns, our study pioneered the application of test‐then‐pool, normalized power prior, calibrated power prior, and elastic prior to a two‐arm information borrowing framework and systematically compared their operating characteristics through a series of simulation studies under most and least desirable scenarios.ResultsIn the most desirable scenarios of information borrowing, all methods managed to control the mean of type I error rates within 5%, among which the normalized power prior, calibrated power prior and elastic prior approaches increased the mean of power from 85.94% to 95%. In the least desirable scenarios, the mean type I error rates for normalized power prior, calibrated power prior and elastic prior approaches exceeded 20%, while the mean power decreased to around 80%.ConclusionsOur findings reveal that the normalized power prior, calibrated power prior and elastic prior approaches are suitable for situations with minimal heterogeneity between historical and current data, whereas the test‐then‐pool approach emerges as a more prudent choice when facing substantial discrepancies between historical and current information for trials consider information borrow in both arms.

Publisher

Wiley

Subject

Health Policy,General Medicine

Reference37 articles.

1. U.S. Food & Drug Administration.Considerations for the design and conduct of externally controlled trials for drug and biological products. (Accessed 15 February 2023).https://www.fda.gov/regulatory‐information/search‐fda‐guidance‐documents/considerations‐design‐and‐conduct‐externally‐controlled‐trials‐drug‐and‐biological‐products

2. U.S. Food & Drug Administration.Interacting with the FDA on complex innovative trial designs for drugs and biological products. (Accessed 20 May 2023).https://www.fda.gov/regulatory‐information/search‐fda‐guidance‐documents/interacting‐fda‐complex‐innovative‐trial‐designs‐drugs‐and‐biological‐products

3. Use of a historical control group in a noninferiority trial assessing a new antibacterial treatment: A case study and discussion of practical implementation aspects

4. A Comparison Between a Meta-analytic Approach and Power Prior Approach to Using Historical Control Information in Clinical Trials With Binary Endpoints

5. Bayesian adaptive design for concurrent trials involving biologically related diseases

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3